Stock comparison
LeMaitre Vascular
STERIS
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LMAT
LeMaitre Vascular
Market cap
$2.23B
Sector
Healthcare
STE
STERIS
Market cap
$21.26B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LMAT | STE | Winner |
|---|---|---|---|
| Warren Buffett | 77B | 53C | LMAT |
| Benjamin Graham | 89A | 68B | LMAT |
| Philip Fisher | 81C | 58C | LMAT |
| Peter Lynch | 67B | 52C | LMAT |
| Joel Greenblatt | 56D | 35D | LMAT |
| Charlie Munger | 68D | 42D | LMAT |
| Terry Smith | 69D | 48D | LMAT |
Side-by-side metrics
| Metric | LMAT | STE |
|---|---|---|
| Market cap | $2.23B | $21.26B |
| P/E (TTM) | 37.1x | 25.3x |
| EV/EBIT | 36.6x | 17.7x |
| ROIC (TTM) | 9.43% | 8.51% |
| Gross margin | 72.39% | 44.25% |
| Net margin | 24.35% | 13.18% |
| Revenue CAGR 5y | 12.75% | 8.88% |
| EPS CAGR 5y | 19.04% | 33.45% |
| Debt / Equity | 0.5x | 0.0x |
| Dividend yield | 0.84% | 1.22% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LMAT leads on
- Net margin24.35%vs 13.18%+46%
- Gross margin72.39%vs 44.25%+39%
- Revenue CAGR 5y12.75%vs 8.88%+30%
- ROIC (TTM)9.43%vs 8.51%+10%
STE leads on
- Debt / Equity0.0xvs 0.5x+96%
- Market cap$21.26Bvs $2.23B+89%
- EV/EBIT17.7xvs 36.6x+52%
- EPS CAGR 5y33.45%vs 19.04%+43%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.